INS and type 1 diabetes mellitus: The limited supply of islet donors and the need for chronic treatment of recipients with immunosuppressors restrict the applicability and long-term efficacy of islet transplantation in patients with type 1 diabetes or type 2 diabetes who require insulin [56].